Skip to main content

3D Protein Structure Analysis Market Size, Share, Growth, Industry Analysis and Forecast 2022-2032

 One of the primary objectives of molecular biology research is to identify the structure of proteins. Protein complex analysis requires a thorough research of proteins' structure and function because they are found in complicated biological samples. The structure of protein complexes can be ascertained using contemporary protein complex analysis methods. Many studies are currently being conducted employing cryo-electron microscopy (EM), small angle X-ray scattering (SAXS), nuclear magnetic resonance (NMR) spectroscopy, and X-ray crystallography to describe and understand molecular structures and molecular recognition mechanisms. Equipment for 3D protein structure analysis is available from reputable manufacturers including Bruker Corporation, JEOL Ltd., and Spectris plc depending on what is required. These tools can meet the laboratory's throughput requirements.

In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032. The growth in the global 3D protein structure analysis market is expected to be driven by technological advancements in equipment for protein structure analysis and by an increase in RD expenditure to accelerate protein structure analysis.

3D Protein Structure Analysis Market

Impact

•   The presence of major equipment providers of 3D protein structure analysis has a major impact on the market. For instance, in April 2022, NJ Biopharmaceuticals LLC and JEOL Ltd. announced their collaboration to bring innovative drug discovery platform solutions using JEOL's 800 MHz NMR. With the help of this partnership, JEOL Ltd. aspires to grow its 3D protein structure analysis base and increase its existing product line.
•   In August 2020, Thermo Fisher Scientific Inc., a global leader in providing scientific services, announced that it would facilitate access to cryo-electron microscopy (cryo-EM) by connecting pharmaceutical and biotechnology companies with contract research organizations (CROs) that provide start-up packages for this game-changing technology as a service.

Recent Developments in Global 3D Protein Structure Analysis Market

•    In February 2022, JEOL Ltd. announced the development of a new cold field emission cryo-electron microscope (cryo-EM), the CRYO ARM 200 II (JEM-Z200CA), dedicated to single particle analysis of proteins.
•    In November 2021, JEOL Ltd. announced the availability of "ECZ Luminous" nuclear magnetic resonance console (JNM-ECZL series). This product is the next step in spectrometer miniaturization and extended performance through state-of-the-art digital and high-frequency technologies.
•    In October 2020, Thermo Fisher Scientific Inc. introduced two ground-breaking imaging filters, i.e., the Thermo Scientific Selectris Imaging Filter and the Thermo Scientific Selectris X Imaging Filter, which elevated cryo-electron microscopy (cryo-EM) to a new level by allowing users to view proteins at true atomic resolution.
•    In April 2021, Thermo Fisher Scientific Inc. unveiled the Thermo Scientific E-CFEG, a significant accessory for the Thermo Scientific Krios Cryo-TEM and the company's new cold field emission gun. In comparison to other commercially available technologies, the E-four CFEG's key components work together to achieve single particle analysis (SPA) resolution levels that are unprecedented.

 

Global 3D Protein Structure Analysis Market Segments

jBb117moRNa2iBL8cifc_06_8ad23f268f2823de966247d2d6ea918a_image.png

 

Demand – Drivers and Limitations

Following are the demand drivers for the global 3D protein structure analysis market:

•    Technological Advancements in Equipment for Protein Structure Analysis
•    Increase in RD Expenditure in Drug Discovery and Development
•    Rising Focus on Automation and Miniaturization in X-Ray Crystallography Workflow

The market is expected to face some limitations too due to the following challenges:

•    Certain Instrument Limitations Pertaining to 3D Protein Structure Analysis
•    Lack of Qualified Personnel
•    High Cost and Time-Consuming Method

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts, analyzing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

•    Bruker Corporation
•    JEOL Ltd.
•    Spectris plc
•    Thermo Fisher Scientific Inc.
•    Merck KGaA
•    Schrodinger, Inc.
•    Molecular Dimensions
•    Arinax Scientific Instrumentation.
•    Cambridge Isotope Laboratories, Inc.
•    HAMPTON RESEARCH CORP.
•    DNASTAR
•    RosettaCommons.org
•    Rigaku Corporation
•    Dassault Systemes
•    Jena Bioscience GmbH

 Get Free Sample Report - https://bisresearch.com/requestsample?id=1364type=download

Key Questions Answered in the Report

  • What are the major market drivers, challenges, and opportunities and their respective impacts in the global 3D protein structure analysis market?
  • What is the potential impact of technological advancements among the key end users, such as biopharmaceutical companies and academic and research institutes?
  • What is the current market demand along with future expected demand for the global 3D protein structure analysis market?
  • What are the key development strategies that have been implemented by the major players in order to sustain the competitive market?
  • Which potential entry barriers are expected to be faced by the companies willing to enter the global 3D protein structure analysis market?
  • How is each segment of the market expected to grow during the forecast period from 2022 to 2032 based on each segment?
  • Following are the segment types:
    • Product (Consumable, Equipment, and Software)
    • End User (Biopharmaceutical Company, Academic and Research Institute, Other End User)
    • Region (North America, Europe, Asia-Pacific, and Rest-of-the-World (RoW))
  • Who are the leading players with significant offerings to the global 3D protein structure analysis market, and what is the expected market dominance for each of these leading players?
  • Which emerging companies are anticipated to be highly disruptive in the future, and what are their key strategies for sustainable growth in the global 3D protein structure analysis market?
  • Which companies are anticipated to be highly disruptive in the future, and why?
  • Who are the leading computational software providers with significant offerings in the global 3D protein structure analysis market?
  • Who are the major equipment manufacturers for different technologies in the global 3D protein structure analysis market?
  • What are the growth opportunities for the companies in the region of their operation?

 

BIS Related Studies

Global Recombinant Cell Culture Supplements Market

Labels:

Comments

Post a Comment

Popular posts from this blog

PP Compound Market for Automotive Industry Open Up New Revenue Opportunities

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020. Market Segmentation Global Polypropylene (PP) Compound Market for Automotive Industry by Applicatio
Post a Comment
Read more

Growing Focus on Patient-Centered Healthcare led to Rise in Urgent Care Apps Market

Urgent care apps are intended to serve patients seeking urgent care by connecting them to a relevant specialist and facilitating further courses of action such as diagnosis, treatment, and monitoring.   Treatment can be offered remotely via text/audio/video calls, or help can be arranged to usher the patient to the nearest hospital. The widespread adoption of smartphones and increased demand for urgent and convenient access to care will be crucial to the market’s growth.  The global urgent care apps market was valued at $973.6 million in 2020 and is anticipated to grow to $10,150.5 million by the end of 2030 at a projected CAGR of 26.32% during the forecast period 2021-2030.   The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no visible impact of COVID-19 beyond 2030. The changes in the market during that timeline can build upon the developments of
Post a Comment
Read more

Neoantigen Cancer Vaccine Market Technology Developments and Future Growth

  Looking at the recent oncology care trends, the World Heart Foundation estimates the global cancer treatment expenditure to reach $XX billion in the year 2031.   The increase in overall burden provides an opportunity for several companies to step in and introduce their innovative products in the market. The emergence of the neoantigen cancer vaccine can be considered as an evident example of emerging oncology care that can possibly prevail over the existing hurdles of treatment un-specificity and safety benchmarks. The global neoantigen cancer vaccine industry analysis by BIS Research projects the market to grow at a significant CAGR of 77.73% during the forecast period 2024-2031. The  neoantigen cancer vaccine market  is expected to generate $35.5 million in revenue in 2024, owing to the expected launch of the first neoantigen vaccine, DC vaccine in the market. The neoantigen cancer vaccine market growth has been primarily attributed to major drivers in this market, such as rising p
Post a Comment
Read more